A guide to when they start working, patient experiences, how long the benefits last — and what to know about Tezepelumab
Biologic treatments — like omalizumab, mepolizumab, benralizumab, dupilumab, and now tezepelumab — have transformed care for people with severe asthma and related lung conditions. But many patients naturally ask:
-
When will I start to feel better?
-
Will the benefit last?
-
Am I eligible for this treatment?
-
What if it wears off or I stop taking it?
-
Which biologic is right for me?
💷 Access to Biologics: Who Can Have Them?
Biologics are highly effective — but they are also expensive treatments, often costing £10,000–£30,000 per year. Because of this, the NHS only offers them to patients who meet strict criteria.
This helps ensure:
-
Fair access
-
Best use of NHS resources
-
That patients are likely to benefit
✅ To qualify for a biologic, patients must typically:
-
Have confirmed severe asthma
-
Symptoms remain poorly controlled despite taking:
-
High-dose inhaled steroids (ICS)
-
Long-acting beta agonists (LABAs)
-
Other controller medication (e.g. montelukast)
-
-
-
Have frequent asthma attacks
-
Usually 2 or more flare-ups in the past year needing:
-
Oral steroids (e.g. prednisolone)
-
A&E or hospital care
-
-
-
Be using their inhalers properly and regularly
-
Doctors will check that medication is being taken as prescribed
-
Inhaler technique must be correct
-
Other problems (like reflux or anxiety) must be addressed first
-
-
Have the right blood or allergy profile
(This depends on which biologic is being considered):
| Biologic | Biomarker Criteria |
|---|---|
| Omalizumab | IgE in range + allergic asthma |
| Mepolizumab/Benralizumab | Eosinophils ≥150–300 cells/µL |
| Dupilumab | Raised FeNO or IgE, plus eosinophilic features |
| Tezepelumab | Works in a wider group, including low eosinophils |
-
Be assessed by a specialist team
-
Biologics are only prescribed after a full multidisciplinary review in a specialist asthma service
-
🔄 After Starting:
-
Patients are reviewed after 3–6 months
-
If there’s no improvement, treatment is stopped
-
Continued use depends on measurable benefit, such as:
-
Fewer attacks
-
Reduced steroid need
-
Better lung function or asthma control scores
-
💬 “Biologics are not a quick fix — but when matched carefully, they can be life-changing.”
⏳ When Will I Start Feeling Better?
Most patients begin to feel some improvement within the first few weeks to three months.
🟩 What Other Patients Say:
-
Lynn (USA):
“Within five days, I could tell … I was not coughing as much.”
-
Mena, 17 (USA):
“She doesn’t have to rely on steroids as much.”
“Now I’m stable.” -
Catherine, 88 (UK):
“Since taking biologics, I’ve not had to call the office about breathing problems once.”
-
UK Patient Survey:
“Biologic treatment stopped the disruption of family and social life.”
“Energy and mental health improved by 3 months.”
📈 Typical Timeline of Benefits:
| Time After Starting | What You May Notice |
|---|---|
| 1–2 weeks | Less coughing, better sleep, reduced night symptoms |
| 2–4 weeks | Easier breathing, less tightness, more energy |
| 1–3 months | Fewer flare-ups, less need for oral steroids |
| 3–6 months | Improved walking, daily life, and lung test scores |
| 12 months | Full review of benefit — continued if effective |
📆 How Long Do the Benefits Last?
If the biologic is working and you stay on treatment, the benefits can last for years:
-
Many patients remain stable for 1–5 years or more
-
Biologics are ongoing treatments — not cures, but long-term control
-
If stopped, some patients stay well for a time, while others relapse
💡 Spotlight on Tezepelumab (Tezspire)
Tezepelumab is a newer biologic that works differently from the others — it targets TSLP, an upstream trigger of inflammation. This makes it suitable for a broader range of asthma patients, including those without high eosinophils or obvious allergies.
🔹 How It Works:
-
Blocks TSLP (thymic stromal lymphopoietin) — a key driver of inflammation
-
Works across multiple asthma types (eosinophilic, allergic, non-allergic)
🔹 Dosing:
-
210 mg injection every 4 weeks (subcutaneous)
🔹 Benefits (NAVIGATOR & DESTINATION trials):
-
Reduces asthma attacks by 56% regardless of eosinophil count or allergic status
-
Improvement often seen within 2–4 weeks, with continued benefit over 1–2 years
-
Long-term studies show sustained effectiveness and good safety
-
After stopping, inflammation gradually returns but may remain better than baseline for a while
🧠 Tezepelumab is especially promising for patients who haven’t responded well to other biologics, or who don’t fit into the eosinophilic or allergic categories.
✅ In Summary:
| Question | Typical Answer |
|---|---|
| When will I feel better? | 2–12 weeks, sometimes faster |
| How long does it last? | Months to years if treatment continues |
| What if I stop? | Symptoms may return gradually |
| Who can get a biologic? | Patients meeting NHS criteria, reviewed by specialists |
| Tezepelumab use? | For broad asthma types, including low-eosinophil asthma |
Share this post
Latest News posts
Aspergillosis Research Update (Week of 16–23 March 2026)
March 23, 2026
Building fitness with Aspergillosis
March 20, 2026
A Drop of Blood, Real-Time Answers
March 20, 2026
Understanding the Journey to Diagnosis (Start Here)
March 20, 2026
Why Diagnosis Can Take Time — and Why You Are Not Alone
March 20, 2026
Why Aspergillosis Is So Hard to Diagnose
March 18, 2026
Aspergillosis Research Highlights – Week 11
March 16, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
